Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Nov 1912:30 PM EST
-01:30 PM EST
Learn how Keshav, a Chartered Accountant, scored an impressive 705 on GMAT in just 30 days with GMATWhiz's expert guidance. In this video, he shares preparation tips and strategies that worked for him, including the mock, time management, and more
Nov 2007:30 AM PST
-08:30 AM PST
Learn what truly sets the UC Riverside MBA apart and how it helps in your professional growth
Nov 2001:30 PM EST
-02:30 PM IST
Learn how Kamakshi achieved a GMAT 675 with an impressive 96th %ile in Data Insights. Discover the unique methods and exam strategies that helped her excel in DI along with other sections for a balanced and high score.
Nov 2211:00 AM IST
-01:00 PM IST
Do RC/MSR passages scare you? e-GMAT is conducting a masterclass to help you learn – Learn effective reading strategies Tackle difficult RC & MSR with confidence Excel in timed test environment- Nov 23
11:00 AM IST
-01:00 PM IST
Attend this free GMAT Algebra Webinar and learn how to master the most challenging Inequalities and Absolute Value problems with ease. 
Nov 2407:00 PM PST
-08:00 PM PST
Full-length FE mock with insightful analytics, weakness diagnosis, and video explanations!
Nov 2510:00 AM EST
-11:00 AM EST
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors.
15 Feb 2022, 23:00
Kudos
Bookmarks
Question 1
E
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
55%
(hard)
Question Stats:
49% (02:25) correct
51%
(02:16) wrong
based on 251
sessions
History
Date
Time
Result
Not Attempted Yet
Question 2
E
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
65%
(hard)
Question Stats:
29% (00:39) correct 71%
(00:38) wrong
based on 221
sessions
History
Date
Time
Result
Not Attempted Yet
Question 3
D
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
75%
(hard)
Question Stats:
38% (01:05) correct 62%
(01:01) wrong
based on 222
sessions
History
Date
Time
Result
Not Attempted Yet
Question 4
E
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
55%
(hard)
Question Stats:
49% (01:15) correct 51%
(01:05) wrong
based on 220
sessions
History
Date
Time
Result
Not Attempted Yet
Question 5
C
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
75%
(hard)
Question Stats:
50% (01:51) correct 50%
(01:40) wrong
based on 187
sessions
History
Date
Time
Result
Not Attempted Yet
A study of the benefits of a family of cholesterol-lowering drugs used in the treatment of heart attacks has shown that while the greatest benefits are enjoyed by those at greatest risk of a vascular event, every person at risk can gain considerable benefits from the treatment.These findings have led to calls that it should be offered to anybody at risk of a heart attack or stroke. It has long been known that the treatment, if administered daily to the group most at risk of an attack, cuts that risk by a third. At present, doctors prescribe the treatment only once they have considered a number of factors, including cholesterol level, blood pressure, body fat levels and whether the patient smokes. The new evidence suggests that patients with less than very high levels of cholesterol will also experience a significant drop in their cholesterol levels and a consequent lower risk of a vascular event. In fact, it concludes that the benefits of the treatment are directly proportional to the size of the reduction in cholesterol levels that might be achieved and not the level at which the intervention begins.
1. Which of the following is a factor that gave rise to the call that the treatment should be offered to anybody at risk of a heart attack or stroke?
A. the realization that the treatment is literally a life saver
B. the realization that not every person at risk can gain considerable benefits from the treatment
C. the realization that in those most at risk the treatment reduces the risk of an attack by as much as a third
D. the realization that the risk of a heart attack is much higher in people who smoke, are overweight and have high cholesterol levels and blood pressure
E. the realization that benefits from the treatment were seen in many different patient types
A. the realization that the treatment is literally a life saver
B. the realization that not every person at risk can gain considerable benefits from the treatment
C. the realization that in those most at risk the treatment reduces the risk of an attack by as much as a third
D. the realization that the risk of a heart attack is much higher in people who smoke, are overweight and have high cholesterol levels and blood pressure
E. the realization that benefits from the treatment were seen in many different patient types
2. The treatment is:
A. a single drug
B. a family of related drugs
C. an unspecified intervention
D. a series of painful injections
E. administered daily
A. a single drug
B. a family of related drugs
C. an unspecified intervention
D. a series of painful injections
E. administered daily
3. The best summary of the conclusion to be drawn from the evidence of the study is that:
A. The benefits of the treatment are directly proportional to the size of the reduction in cholesterol levels that might be achieved and not the level at which intervention begins.
B. This treatment could cut heart attacks by a third.
C. The treatment should be prescribed to anyone assessed to be at risk of a heart attack or stroke.
D. There is now a much stronger case for the treatment to be prescribed to a much wider group of patients.
E. The greatest benefits are enjoyed by those at greatest risk of a vascular event.
A. The benefits of the treatment are directly proportional to the size of the reduction in cholesterol levels that might be achieved and not the level at which intervention begins.
B. This treatment could cut heart attacks by a third.
C. The treatment should be prescribed to anyone assessed to be at risk of a heart attack or stroke.
D. There is now a much stronger case for the treatment to be prescribed to a much wider group of patients.
E. The greatest benefits are enjoyed by those at greatest risk of a vascular event.
4. Given that the benefits of the treatment are directly proportional to the size of the reduction in cholesterol levels it is correct to say that:
A. Doctors should offer this treatment to everybody they believe are at risk of a heart attack regardless of their cholesterol levels.
B. Taking the treatment on a daily basis can cut the risk of a heart attack and stroke by a third.
C. The treatment may not benefit as wide a range of patients as was originally thought.
D. Everyone could gain considerable benefits from the treatment.
E. Doctors should look more to the relative drop in cholesterol that may be achieved, rather than prioritizing patients suffering the very highest levels.
A. Doctors should offer this treatment to everybody they believe are at risk of a heart attack regardless of their cholesterol levels.
B. Taking the treatment on a daily basis can cut the risk of a heart attack and stroke by a third.
C. The treatment may not benefit as wide a range of patients as was originally thought.
D. Everyone could gain considerable benefits from the treatment.
E. Doctors should look more to the relative drop in cholesterol that may be achieved, rather than prioritizing patients suffering the very highest levels.
5. Which of the statements, if true, would most weaken the claim that patients with less than very high levels of cholesterol will also experience a significant drop in their cholesterol levels and consequently a much lower risk of a vascular event?
A. The largest benefits from the treatment are seen among those in greatest risk of a vascular event, and those with less than very high levels of cholesterol are not at greatest risk.
B. Unfortunately, the best results from the treatment are only obtained when the treatment is customized to the individual patient’s cholesterol levels and requires someone with less than very high cholesterol levels to take a smaller daily dose.
C. Preliminary evidence suggests that the treatment achieves a relatively small reduction in the risk of a heart attack among people with less than very high levels of cholesterol.
D. Not all the evidence is positive, as people with lower cholesterol levels who take the treatment have been found to develop an increased risk of some cancers.
E. Originally, it was thought that the treatment worked by lowering the cholesterol level, but it is now believed that this effect alone is not enough to account for all the advantages that the treatment provides.
A. The largest benefits from the treatment are seen among those in greatest risk of a vascular event, and those with less than very high levels of cholesterol are not at greatest risk.
B. Unfortunately, the best results from the treatment are only obtained when the treatment is customized to the individual patient’s cholesterol levels and requires someone with less than very high cholesterol levels to take a smaller daily dose.
C. Preliminary evidence suggests that the treatment achieves a relatively small reduction in the risk of a heart attack among people with less than very high levels of cholesterol.
D. Not all the evidence is positive, as people with lower cholesterol levels who take the treatment have been found to develop an increased risk of some cancers.
E. Originally, it was thought that the treatment worked by lowering the cholesterol level, but it is now believed that this effect alone is not enough to account for all the advantages that the treatment provides.
RC Butler 2022 - Practice Two RC Passages Everyday.
Passage # 69 Date: 16-Feb-2022
This question is a part of RC Butler 2022. Click here for Details
Passage # 69 Date: 16-Feb-2022
This question is a part of RC Butler 2022. Click here for Details
Source: How to pass the GMAT
04 Mar 2022, 05:08
Kudos
Bookmarks
Official Explanation
3. The best summary of the conclusion to be drawn from the evidence of the study is that:
Explanation
Suggested answer D best summarizes the conclusion because it states who can benefit from the treatment given the evidence now available.
Answer: D
Explanation
Suggested answer D best summarizes the conclusion because it states who can benefit from the treatment given the evidence now available.
Answer: D
GoodDay22
